Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4373 | 532-32-1 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
The sodium salt of BENZOIC ACID. It is used as an antifungal preservative in pharmaceutical preparations and foods. It may also be used as a test for liver function.
|
None
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Dec. 23, 1987 | FDA |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Creatinine renal clearance decreased | 174.20 | 124.24 | 39 | 774 | 18860 | 90608774 |
| Sedation complication | 167.31 | 124.24 | 37 | 776 | 16907 | 90610727 |
| Orthostatic hypotension | 157.61 | 124.24 | 42 | 771 | 41785 | 90585849 |
| Blood calcium decreased | 156.04 | 124.24 | 39 | 774 | 30143 | 90597491 |
| Sedation | 128.92 | 124.24 | 37 | 776 | 48134 | 90579500 |
| Cognitive disorder | 128.10 | 124.24 | 40 | 773 | 69367 | 90558267 |
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Creatinine renal clearance decreased | 184.97 | 98.09 | 42 | 941 | 21773 | 110566543 |
| Sedation complication | 177.93 | 98.09 | 40 | 943 | 19815 | 110568501 |
| Blood calcium decreased | 164.24 | 98.09 | 42 | 941 | 35803 | 110552513 |
| Orthostatic hypotension | 151.74 | 98.09 | 45 | 938 | 66204 | 110522112 |
| Cognitive disorder | 135.30 | 98.09 | 44 | 939 | 87467 | 110500849 |
| Sedation | 123.94 | 98.09 | 39 | 944 | 69644 | 110518672 |
| Depressed level of consciousness | 116.93 | 98.09 | 42 | 941 | 112236 | 110476080 |
| Balance disorder | 115.40 | 98.09 | 42 | 941 | 116518 | 110471798 |
| Hyperammonaemia | 108.49 | 98.09 | 25 | 958 | 13707 | 110574609 |
None
| Source | Code | Description |
|---|---|---|
| ATC | A16AX11 | ALIMENTARY TRACT AND METABOLISM OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS Various alimentary tract and metabolism products |
| ATC | A16AX30 | ALIMENTARY TRACT AND METABOLISM OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS Various alimentary tract and metabolism products |
| ATC | V04CG30 | VARIOUS DIAGNOSTIC AGENTS OTHER DIAGNOSTIC AGENTS Tests for gastric secretion |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000935 | Antifungal Agents |
| MeSH PA | D005503 | Food Additives |
| MeSH PA | D005520 | Food Preservatives |
| CHEBI has role | CHEBI:35476 | antipsychotic agent |
| CHEBI has role | CHEBI:64996 | EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor |
| CHEBI has role | CHEBI:65001 | EC 3.1.1.3 (triacylglycerol lipase) inhibitor |
| CHEBI has role | CHEBI:65256 | antimicrobial food preservative |
| CHEBI has role | CHEBI:76924 | plant metabolite |
| CHEBI has role | CHEBI:76967 | human xenobiotic metabolite |
| CHEBI has role | CHEBI:84735 | algal metabolite |
| CHEBI has role | CHEBI:88188 | drug allergen |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Hyperammonemia | indication | 9360008 | |
| Apnea in the newborn | indication | 13094009 | |
| Fatigue | off-label use | 84229001 | |
| Drowsy | off-label use | 271782001 | |
| Necrotizing enterocolitis in fetus OR newborn | contraindication | 2707005 | |
| Peptic ulcer | contraindication | 13200003 | DOID:750 |
| Hypertensive disorder | contraindication | 38341003 | DOID:10763 |
| Hypokalemia | contraindication | 43339004 | |
| Body fluid retention | contraindication | 43498006 | |
| Conduction disorder of the heart | contraindication | 44808001 | |
| Chronic heart failure | contraindication | 48447003 | |
| Acute nephropathy | contraindication | 58574008 | |
| Metabolic acidosis | contraindication | 59455009 | |
| Hepatic failure | contraindication | 59927004 | |
| Agoraphobia | contraindication | 70691001 | DOID:593 |
| Hyperglycemia | contraindication | 80394007 | DOID:4195 |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Seizure disorder | contraindication | 128613002 | |
| Obsessive-compulsive disorder | contraindication | 191736004 | DOID:10933 |
| Insomnia | contraindication | 193462001 | |
| Impaired renal function disorder | contraindication | 197663003 | |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Edema | contraindication | 267038008 | |
| Panic disorder | contraindication | 371631005 | DOID:594 |
| Myocardial ischemia | contraindication | 414795007 | DOID:3393 |
| Myocardial infarction in recovery phase | contraindication | 418044006 | |
| CNS Toxicity | contraindication |
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Carbonic anhydrase 2 | Enzyme | Ki | 4.52 | CHEMBL | |||||
| Carbonic anhydrase 4 | Enzyme | Ki | 4.13 | CHEMBL | |||||
| Carbonic anhydrase | Enzyme | Ki | 4.61 | CHEMBL |
| ID | Source |
|---|---|
| D02277 | KEGG_DRUG |
| 4017797 | VUID |
| N0000146158 | NUI |
| 4017797 | VANDF |
| C0142805 | UMLSCUI |
| CHEBI:113455 | CHEBI |
| CHEMBL1356 | ChEMBL_ID |
| OJ245FE5EU | UNII |
| 517055 | PUBCHEM_CID |
| 56455 | RXNORM |
| 5206 | MMSL |
| 5472 | MMSL |
| d03096 | MMSL |
| 001243 | NDDF |
| 003194 | NDDF |
| 125706008 | SNOMEDCT_US |
| 398718007 | SNOMEDCT_US |
| D020160 | MESH_DESCRIPTOR_UI |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Ammonul | HUMAN PRESCRIPTION DRUG LABEL | 2 | 62592-720 | INJECTION, SOLUTION, CONCENTRATE | 100 mg | INTRAVENOUS | NDA | 28 sections |
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | HUMAN PRESCRIPTION DRUG LABEL | 2 | 68382-396 | INJECTION, SOLUTION, CONCENTRATE | 100 mg | INTRAVENOUS | ANDA | 24 sections |
| Sodium Phenylacetate and sodium benzoate | HUMAN PRESCRIPTION DRUG LABEL | 2 | 68475-001 | INJECTION, SOLUTION, CONCENTRATE | 100 mg | INTRAVENOUS | ANDA | 24 sections |
| Sodium phenylacetate and Sodium benzoate | HUMAN PRESCRIPTION DRUG LABEL | 2 | 68475-513 | INJECTION, SOLUTION, CONCENTRATE | 100 mg | INTRAVENOUS | ANDA | 24 sections |
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | HUMAN PRESCRIPTION DRUG LABEL | 2 | 70511-101 | INJECTION, SOLUTION, CONCENTRATE | 100 mg | INTRAVENOUS | ANDA | 28 sections |
| Sodium Phenylacetate and Sodium Benzoate | HUMAN PRESCRIPTION DRUG LABEL | 2 | 70511-102 | INJECTION | 100 mg | INTRAVENOUS | NDA | 29 sections |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | HUMAN PRESCRIPTION DRUG LABEL | 2 | 70556-100 | INJECTION, SOLUTION, CONCENTRATE | 100 mg | INTRAVENOUS | ANDA | 28 sections |
| Sodium phenylacetate and Sodium benzoate | HUMAN PRESCRIPTION DRUG LABEL | 2 | 70710-1926 | INJECTION, SOLUTION, CONCENTRATE | 100 mg | INTRAVENOUS | ANDA | 24 sections |
| Sodium Phenylacetate and Sodium Benzoate | HUMAN PRESCRIPTION DRUG LABEL | 2 | 72266-236 | INJECTION | 100 mg | INTRAVENOUS | NDA | 29 sections |
| seo jeong ho hwang chill mist | HUMAN OTC DRUG LABEL | 1 | 76675-0006 | LIQUID | 0.50 g | TOPICAL | unapproved drug other | 7 sections |
| seo jeong ho hwang chill deodorant | HUMAN OTC DRUG LABEL | 1 | 76675-0008 | LIQUID | 0.50 g | TOPICAL | unapproved drug other | 7 sections |
| s panax mist for refill | HUMAN OTC DRUG LABEL | 1 | 76675-0011 | LIQUID | 0.50 g | TOPICAL | unapproved drug other | 7 sections |
| s panax mist | HUMAN OTC DRUG LABEL | 1 | 76675-0013 | LIQUID | 0.50 g | TOPICAL | unapproved drug other | 7 sections |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | HUMAN PRESCRIPTION DRUG LABEL | 2 | 81665-203 | INJECTION, SOLUTION, CONCENTRATE | 100 mg | INTRAVENOUS | ANDA | 28 sections |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | HUMAN PRESCRIPTION DRUG LABEL | 2 | 81665-204 | INJECTION, SOLUTION, CONCENTRATE | 100 mg | INTRAVENOUS | ANDA | 28 sections |
| s panax all in one mist | HUMAN OTC DRUG LABEL | 1 | 81885-0002 | LIQUID | 0.50 g | TOPICAL | unapproved drug other | 7 sections |
| GKV Anti Dandruff Smooth | HUMAN OTC DRUG LABEL | 7 | 84558-001 | SHAMPOO | 0.40 g | TOPICAL | OTC Monograph Drug | 12 sections |